Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson’s Disease

被引:0
作者
Pengyue Wu
Yuxuan Dong
Jinhu Chen
Tianyuan Guan
Bing Cao
Yanqiu Zhang
Yueyan Qi
Zhenlong Guan
Yanqin Wang
机构
[1] Hebei Normal University,Department of Physiology, College of Life Sciences
[2] Hebei General Hospital,Department of Endocrinology
[3] Hebei General Hospital,Department of Neurology
来源
Neurotoxicity Research | 2022年 / 40卷
关键词
Parkinson’s disease; PGC-1α; Mitochondria quality control; Mitochondrial biogenesis; Mitochondrial dynamics; Autophagy;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a multifactorial disorder, and there is strong evidence that mitochondria play an essential role in the disorder. Factors that regulate the mechanism of the mitochondrial quality control system have been drawing more and more attention. PGC-1α (peroxisome proliferator-activated receptor-γ coactivator-1α) is a powerful transcription factor involved in regulation of mitochondrial function. Glucagon-like peptide 1 (GLP-1), a brain-gut peptide, can enter the central nervous system through the blood–brain barrier and play neuroprotective role. However, whether the GLP-1R agonist liraglutide regulates mitochondrial quality control system through PGC-1α is still unclear. We administered different doses of liraglutide to intervene MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced PD model, and then immunofluorescence, Western blot, and stereotactic injection of lentivirus to downregulate PGC-1α were used to explore the mechanisms underlying the protective effect of liraglutide in PD. The results showed that MPTP lead to decreased mitochondrial biogenesis, disrupted mitochondrial dynamics, inhibited mitochondrial autophagy, and promoted cell apoptosis. While liraglutide effectively attenuated the neurotoxicity of MPTP, including reversing the dyskinesia caused by MPTP and preserving the expression of GLP-1R, TH, and PGC-1α in the substantia nigra (SN), further experiments showed that downregulation of PGC-1α expression via stereotactic injection PGC-1α lentivirus into the SN reversed the liraglutide protective effects. By PGC-1α downregulation, we found that PGC-1α can not only regulate mitochondria biogenesis, mitochondria dynamics, and autophagy, but also regulate cell apoptosis. In summary, liraglutide has a neuroprotective effect in the PD model induced by MPTP. This protective effect is accomplished by activating PGC-1α, which regulates the mitochondrial quality control system.
引用
收藏
页码:286 / 297
页数:11
相关论文
共 221 条
[21]  
Schapira A(2020)Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model Life Sci 256 117824-343
[22]  
Brauer R(2014)The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis J Neural Transm (vienna) 121 123-3797
[23]  
Wei L(2019)Long-term liraglutide ameliorates nigrostriatal impairment via regulating AMPK/PGC-1a signaling in diabetic mice Brain Res 1714 126-90
[24]  
Ma T(2019)Mutual antagonism of PINK1/Parkin and PGC-1α contributes to maintenance of mitochondrial homeostasis in rotenone-induced neurotoxicity Neurotox Res 35 331-90
[25]  
Athauda D(2017)The interaction of mitochondrial biogenesis and fission/fusion mediated by PGC-1α regulates rotenone-induced dopaminergic neurotoxicity Mol Neurobiol 54 3783-2186
[26]  
Girges C(2003)Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator Endocr Rev 24 78-1599
[27]  
Vijiaratnam N(2019)Parkinson's disease: mechanisms, translational models and management strategies Life Sci 226 77-702
[28]  
Auld G(2012)Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer FASEB J 26 2175-7221
[29]  
Whittlesea C(2012)Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders Br J Pharmacol 166 1586-1791
[30]  
Wong I(2011)PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease Cell 144 689-113